In the past decade, there has been renewed interest in immune/inflammatory changes and
their associated oxidative/nitrosative consequences as key pathophysiological mechanisms …

Schizophrenia is a heterogeneous psychiatric disorder with a broad spectrum of clinical and
biological manifestations. Due to the lack of objective tests, the accurate diagnosis and …

A minimally invasive diagnostic assay for early detection of Alzheimer's disease (AD) is
required to select optimal patient groups in clinical trials, monitor disease progression and …

Objective To identify plasma biomarkers for the diagnosis of Alzheimer disease (AD). Design
Baseline plasma screening of 151 multiplexed analytes combined with targeted biomarker …

Context Evidence for symptomatic convergence of schizophrenia and N-methyl-D-aspartate
glutamate receptor (NMDA-R) encephalitis highlights the need for an assessment of …

Abstract Language abnormalities are a core symptom of schizophrenia-spectrum disorders
and could serve as a potential diagnostic marker. Natural language processing enables …

Schizophrenia has been associated with central nervous system and peripheral immune
system imbalances. However, most studies have not yielded conclusive results due to …

Biomarkers are now used in many areas of medicine but are still lacking for psychiatric
conditions such as schizophrenia (SCZ). We have used a multiplex molecular profiling …

Biomarkers have been sought after in the field of schizophrenia research for decades. In this
paper, we discuss some of the concepts around developing biomarkers in an effort to …

Brain extracellular matrix (ECM) is a highly organized system that consists of collagens,
noncollagenous proteins, glycoproteins, hyaluronan, and proteoglycans. Recognized …